• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用211At标记的凝集素和抗体对细胞克隆增殖的特异性抑制——I

The specific inhibition of cellular clonogenic proliferation using 211At labelled lectins and antibodies--I.

作者信息

Vaughan A T, Bateman W J, Brown G, Cowan J

出版信息

Int J Nucl Med Biol. 1982;9(3):167-71. doi: 10.1016/0047-0740(82)90091-2.

DOI:10.1016/0047-0740(82)90091-2
PMID:6957405
Abstract

A monoclonal antibody with a broad anti-human leucocyte specificity, designated BK 19.45 and the plant lectin Concanavalin A have been labelled with the alpha-emitting cyclotron produced radiohalogen astatine-211. Both human and murine tumour cell lines and human leukemic bone marrow samples have been specifically labelled with these radioactive proteins. In all cases the amount of 211At bound to the cells is directly correlated with a decrease in cellular reproductive potential as shown by the ability of the cells to proliferate in a clonogenic assay. For the labelled monoclonal antibody experiments, the radiation dose needed to yield 37% cell survival, the D37 dose, may be achieved with an average of 12 211At atoms/cell.

摘要

一种具有广泛抗人白细胞特异性的单克隆抗体,命名为BK 19.45,以及植物凝集素伴刀豆球蛋白A,已用α发射回旋加速器产生的放射性卤素砹-211进行了标记。人和鼠的肿瘤细胞系以及人白血病骨髓样本都已被这些放射性蛋白质特异性标记。在所有情况下,与细胞结合的砹-211的量与细胞繁殖潜能的降低直接相关,这通过细胞在克隆形成试验中的增殖能力得以体现。对于标记单克隆抗体的实验,产生37%细胞存活率所需的辐射剂量,即D37剂量,平均每个细胞有12个砹-211原子时即可达到。

相似文献

1
The specific inhibition of cellular clonogenic proliferation using 211At labelled lectins and antibodies--I.使用211At标记的凝集素和抗体对细胞克隆增殖的特异性抑制——I
Int J Nucl Med Biol. 1982;9(3):167-71. doi: 10.1016/0047-0740(82)90091-2.
2
The in vivo fate of a 211At labelled monoclonal antibody with known specificity in a murine system.一种具有已知特异性的211砹标记单克隆抗体在小鼠系统中的体内命运。
Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1943-6. doi: 10.1016/0360-3016(82)90453-9.
3
Preparation and evaluation of 211At labelled antineoplastic antibodies.211At标记抗肿瘤抗体的制备与评价
J Pharm Pharm Sci. 2007;10(2):277s-285s.
4
Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.211At和131I标记的单克隆抗体MOv18对人卵巢癌腹腔生长裸鼠的治疗效果比较
Anticancer Res. 2001 Jan-Feb;21(1A):409-12.
5
Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.用211At标记的单克隆抗体体外治疗人骨肉瘤微集落的治疗增益分析。
Br J Cancer. 1994 Jun;69(6):1000-5. doi: 10.1038/bjc.1994.196.
6
Sodium-iodide symporter positive cells after intracellular uptake of (99m)Tc versus α-emitter 211At. Reduction of clonogenic survival and characterization of DNA damage.(99m)Tc与α发射体211At细胞内摄取后碘化钠同向转运体阳性细胞。克隆形成存活率的降低及DNA损伤的特征分析。
Nuklearmedizin. 2012;51(5):170-8. doi: 10.3413/Nukmed-0506-12-05.
7
The in vitro radiobiology of astatine-211 decay.砹-211衰变的体外放射生物学
Radiat Res. 1986 Jan;105(1):27-36.
8
Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.211At-TP-3单克隆抗体在体外对人骨肉瘤细胞的灭活作用:与211At标记的牛血清白蛋白、游离211At及外照射X射线的比较
Radiat Res. 1994 Aug;139(2):178-84.
9
Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.利用211At标记的单克隆抗体MOv18对裸鼠腹膜内生长的卵巢癌异种移植瘤进行放射免疫治疗。
Anticancer Res. 2000 Jan-Feb;20(1A):459-62.
10
Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and retention.[211At]砹标记的C215单克隆抗体的单细胞照射:通过细胞摄取和滞留测量改进放射敏感性估计
Anticancer Res. 2003 Mar-Apr;23(2B):1219-21.

引用本文的文献

1
Astatine Radiopharmaceuticals: Prospects and Problems.砹放射性药物:前景与问题
Curr Radiopharm. 2008 Sep 1;1(3):177. doi: 10.2174/1874471010801030177.
2
Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.用211At标记的单克隆抗体体外治疗人骨肉瘤微集落的治疗增益分析。
Br J Cancer. 1994 Jun;69(6):1000-5. doi: 10.1038/bjc.1994.196.
3
Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.抗体介导的靶向作用在癌症治疗与诊断中的概述
Cancer Chemother Pharmacol. 1986;17(3):197-208. doi: 10.1007/BF00256685.
4
Localization of bismuth radiotracer in rat kidney following exposure to bismuth.铋暴露后大鼠肾脏中铋放射性示踪剂的定位
Biol Trace Elem Res. 1989 Mar;19(3):185-94. doi: 10.1007/BF02924295.
5
Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.用发射α粒子的核素砹-211标记单克隆抗体和F(ab')2片段:免疫反应性和体内定位能力的保留
Proc Natl Acad Sci U S A. 1989 Sep;86(18):7149-53. doi: 10.1073/pnas.86.18.7149.